Company Filing History:
Years Active: 2020
Title: Laura H. Rosenberg: Innovator in Cancer Treatment
Introduction
Laura H. Rosenberg is a prominent inventor based in Ilford, GB. She has made significant contributions to the field of cancer research, particularly in the treatment of breast cancer. Her innovative approach focuses on targeting specific kinases involved in cancer progression.
Latest Patents
Laura H. Rosenberg holds a patent for her invention titled "Therapeutic targeting of casein kinase 1δ in breast cancer." This patent describes a method of inhibiting casein kinase 1δ (CK1δ) by contacting it with a compound of formula (I), such as compound SR-3029. The invention demonstrates that CSNK1D is amplified and/or overexpressed in human breast tumors, allowing for medical targeting in various breast cancer subtypes that overexpress this kinase. Furthermore, the invention provides a method of treating several types of cancer, including breast cancer, melanoma, glioblastoma, and others, particularly those that metastasize to critical areas such as the brain and lungs.
Career Highlights
Laura is affiliated with The Scripps Research Institute, where she continues her groundbreaking work in cancer research. Her dedication to understanding the molecular mechanisms of cancer has positioned her as a key figure in the field.
Collaborations
Throughout her career, Laura has collaborated with esteemed colleagues, including William R. Roush and Derek R. Duckett. These partnerships have further enhanced her research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Laura H. Rosenberg's innovative work in targeting CK1δ in breast cancer exemplifies her commitment to improving cancer therapies. Her contributions are paving the way for more effective treatments and better patient outcomes.